Originally isolated from human gastric juice, BPC157 is widely studied for its potential healing and regenerative properties, particularly in soft tissues, joints, the gastrointestinal tract, nerves, and blood vessels
Eligibility generally includes: A BMI of 30 or above Or a BMI of 27 or above with weight-related health conditions It may not be suitable for individuals with certain medical histories, including specific thyroid conditions or severe gastrointestinal disorders
People following keto or low-carb diets who need metabolic support
Systemic anti-inflammation: All three peptides downregulate NF-kB and TNF-alpha pathways, reducing joint pain, swelling, and localized tissue inflammation
The program gives Medicare beneficiaries temporary access to medications that can support meaningful weight loss while policymakers evaluate longer-term solutions